JP2000501386A5 - - Google Patents

Download PDF

Info

Publication number
JP2000501386A5
JP2000501386A5 JP1997519166A JP51916697A JP2000501386A5 JP 2000501386 A5 JP2000501386 A5 JP 2000501386A5 JP 1997519166 A JP1997519166 A JP 1997519166A JP 51916697 A JP51916697 A JP 51916697A JP 2000501386 A5 JP2000501386 A5 JP 2000501386A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997519166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000501386A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1996/018632 external-priority patent/WO1997017990A1/en
Publication of JP2000501386A publication Critical patent/JP2000501386A/ja
Publication of JP2000501386A5 publication Critical patent/JP2000501386A5/ja
Ceased legal-status Critical Current

Links

JP9519166A 1995-11-14 1996-11-12 角膜損傷に関連する病態を処置するための、殺菌性/透過性増強(bpi)タンパク質 Ceased JP2000501386A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55728995A 1995-11-14 1995-11-14
US08/557,289 1995-11-14
PCT/US1996/018632 WO1997017990A1 (en) 1995-11-14 1996-11-12 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury

Publications (2)

Publication Number Publication Date
JP2000501386A JP2000501386A (ja) 2000-02-08
JP2000501386A5 true JP2000501386A5 (OSRAM) 2004-10-21

Family

ID=24224809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9519166A Ceased JP2000501386A (ja) 1995-11-14 1996-11-12 角膜損傷に関連する病態を処置するための、殺菌性/透過性増強(bpi)タンパク質

Country Status (6)

Country Link
US (2) US20020128191A1 (OSRAM)
EP (1) EP0861088A1 (OSRAM)
JP (1) JP2000501386A (OSRAM)
AU (1) AU730307B2 (OSRAM)
CA (1) CA2235626C (OSRAM)
WO (1) WO1997017990A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
CA2227292A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7029712B1 (en) 2002-07-17 2006-04-18 Biosyntrx Inc Treatment for dry eye syndrome
WO2004006801A2 (en) * 2002-07-17 2004-01-22 Biosyntrx, Inc. Treatment for dry eye syndrome
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
JP5117384B2 (ja) * 2005-07-01 2013-01-16 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 点眼剤の形態における眼用生理学的サプリメントまたは医薬の調製のためのl−カルニチンまたはアルカノイルl−カルニチンの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
WO1991016066A1 (en) * 1990-04-23 1991-10-31 Magainin Sciences Inc. Composition and treatment with biologically active peptides and toxic cations
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
WO1994017819A1 (en) * 1993-02-02 1994-08-18 Xoma Corporation Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation

Similar Documents

Publication Publication Date Title
JP2000500445A5 (OSRAM)
JP2000500033A5 (OSRAM)
JP2000500228A5 (OSRAM)
JPH11506662A5 (OSRAM)
JP2000500327A5 (OSRAM)
JPH11509394A5 (OSRAM)
JP2000500145A5 (OSRAM)
JP2000500155A5 (OSRAM)
JPH11513809A5 (OSRAM)
JP2000502385A5 (OSRAM)
JP2000500115A5 (OSRAM)
JPH11509510A5 (OSRAM)
JP2000500322A5 (OSRAM)
JP2000500258A5 (OSRAM)
JP2000500342A5 (OSRAM)
JP2000500192A5 (OSRAM)
JP2000500112A5 (OSRAM)
JP2000500226A5 (OSRAM)
JP2000500051A5 (OSRAM)
JP2000500019A5 (OSRAM)
JP2000501500A5 (OSRAM)
JPH11508866A5 (OSRAM)
JP2000500166A5 (OSRAM)
JP2000500125A5 (OSRAM)
JP2000500044A5 (OSRAM)